(Q39978617)

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

16 September 2017

2 references

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

A modified version of galectin-9 induces cell cycle arrest and apoptosis of Burkitt and Hodgkin lymphoma cells (English)

1 reference

16 September 2017

0 references

0 references

1 reference

Shoko Makishi

1

1 reference

16 September 2017

Taeko Okudaira

2

1 reference

16 September 2017

Chie Ishikawa

3

1 reference

16 September 2017

Shigeki Sawada

4

1 reference

16 September 2017

Toshiki Watanabe

5

1 reference

16 September 2017

Mitsuomi Hirashima

6

1 reference

16 September 2017

Hajime Sunakawa

7

1 reference

16 September 2017

Naoki Mori

8

1 reference

16 September 2017

language of work or name

English

0 references

publication date

22 May 2008

1 reference

British Journal of Haematology

16 September 2017

published in

1 reference

16 September 2017

volume

142

1 reference

16 September 2017

issue

4

1 reference

16 September 2017

page(s)

583-594

1 reference

Cyclin-dependent kinase inhibitors and JNK act as molecular switches, regulating the choice between growth arrest and apoptosis induced by galectin-8

16 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07229.X

Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07229.X

Is endemic Burkitt's lymphoma an alliance between three infections and a tumour promoter?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07229.X

Targeted induction of apoptosis for cancer therapy: current progress and prospects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07229.X

Functional analysis of the human cyclin D2 and cyclin D3 promoters

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07229.X

Site-specific phosphorylation of IkappaBalpha by a novel ubiquitination-dependent protein kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07229.X

Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB control

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07229.X

God must love galectins; he made so many of them

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07229.X

IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07229.X

Part II: Hodgkin's lymphoma--diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07229.X

NF-kB in development and progression of human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07229.X

Interaction of an NF-kappa B-like factor with a site upstream of the c-myc promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07229.X

The biology of signal transduction inhibition: basic science to novel therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07229.X

Ah, sweet mystery of death! Galectins and control of cell fate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07229.X

AP-1 subunits: quarrel and harmony among siblings

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07229.X

NF-kappaB function in growth control: regulation of cyclin D1 expression and G0/G1-to-S-phase transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07229.X

Direct trans-activation of the human cyclin D2 gene by the oncogene product Tax of human T-cell leukemia virus type I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07229.X

Molecular mechanism of cell cycle progression induced by the oncogene product Tax of human T-cell leukemia virus type I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07229.X

Cellular and molecular signal transduction pathways modulated by rituximab (rituxan, anti-CD20 mAb) in non-Hodgkin's lymphoma: implications in chemosensitization and therapeutic intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07229.X

Transcriptional activation of survivin through the NF-kappaB pathway by human T-cell leukemia virus type I tax.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07229.X

Targeting NF-kappaB and induction of apoptosis by novel NF-kappaB inhibitor dehydroxymethylepoxyquinomicin (DHMEQ) in Burkitt lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07229.X

STAT3 is constitutively activated in Hodgkin cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07229.X

Galectins: a new family of regulators of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07229.X

Intracellular functions of galectins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07229.X

Characterization of galectin-9-induced death of Jurkat T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07229.X

Inhibition of NF-kappaB essentially contributes to arsenic-induced apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07229.X

Human ecalectin, a variant of human galectin-9, is a novel eosinophil chemoattractant produced by T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07229.X

Requirement of divalent galactoside-binding activity of ecalectin/galectin-9 for eosinophil chemoattraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07229.X

Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07229.X

Modern management of non-Hodgkin lymphoma in HIV-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07229.X

Development of highly stable galectins: truncation of the linker peptide confers protease-resistance on tandem-repeat type galectins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07229.X

A modified version of galectin-9 suppresses cell growth and induces apoptosis of human T-cell leukemia virus type I-infected T-cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07229.X

15-Deoxy-delta 12,14-prostaglandin J2 induces apoptosis in human malignant B cells: an effect associated with inhibition of NF-kappa B activity and down-regulation of antiapoptotic proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07229.X

Galectins: an evolutionarily conserved family of animal lectins with multifunctional properties; a trip from the gene to clinical therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07229.X

AP-1 in cell proliferation and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07229.X

An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07229.X

Nuclear factor (NF)-kappaB-regulated X-chromosome-linked iap gene expression protects endothelial cells from tumor necrosis factor alpha-induced apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07229.X

Galectin-3 and galectin-1 bind distinct cell surface glycoprotein receptors to induce T cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07229.X

Galectin-8 induces apoptosis in the CD4(high)CD8(high) thymocyte subpopulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07229.X

Molecular definition of a novel human galectin which is immunogenic in patients with Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07229.X

Developmental regulation, expression, and apoptotic potential of galectin-9, a beta-galactoside binding lectin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07229.X

Induction of cell cycle arrest and apoptosis by the proteasome inhibitor PS-341 in Hodgkin disease cell lines is independent of inhibitor of nuclear factor-kappaB mutations or activation of the CD30, CD40, and RANK receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07229.X

The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07229.X

Characterization of NF-kappaB expression in Hodgkin's disease: inhibition of constitutively expressed NF-kappaB results in spontaneous caspase-independent apoptosis in Hodgkin and Reed-Sternberg cells

21 January 2018

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1111/J.1365-2141.2008.07229.X

Aberrant NF-kappaB signaling in lymphoma: mechanisms, consequences, and therapeutic implications

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1111/J.1365-2141.2008.07229.X

Transcriptional regulation of the bcl-x gene encoding the anti-apoptotic Bcl-xL protein by Ets, Rel/NFkappaB, STAT and AP1 transcription factor families

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1111/J.1365-2141.2008.07229.X

IkappaBalpha independent induction of NF-kappaB and its inhibition by DHMEQ in Hodgkin/Reed-Sternberg cells

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1111/J.1365-2141.2008.07229.X

Regulation of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in Burkitt's lymphoma cell lines

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1111/J.1365-2141.2008.07229.X

Structural features of galectin-9 and galectin-1 that determine distinct T cell death pathways

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1111/J.1365-2141.2008.07229.X

Identifiers

DOI

10.1111/J.1365-2141.2008.07229.X

1 reference

16 September 2017

1 reference